Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG)

Project: Research

Project Details

StatusFinished
Effective start/end date01/10/14 → 01/9/16

Funding

  • Quintiles Incorporated